Table 2.

Cumulative incidence estimates for breast cancer at 10, 20, and 25 years among allogeneic female HCT patients surviving at least 5 years after transplantation (N = 3337)

	Cumulative incidence, % (95% CI)
	10 y	20 y	25 y
Location
FHCRC	1 (0.5-2.0)	3.4 (1.9-5.5)	13 (6.9-22.7)
EBMT	0.6 (0.3-1.1)	7.6 (4.0-12.8)	9.1 (4.9-14.8)
TBI
No	0.1 (0.02-0.8)	1.3 (0.4-3.3)	2.8 (0.7-7.4)
Yes	1.1 (0.6-1.7)	6.1 (3.9-8.9)	16.9 (9.4-26.2)
Age at transplantation
Younger than 18 y	0 (−)	2.8 (1.0-6.1)	6.5 (2.3-13.8)
18 to 39 y	0.6 (0.3-1.2)	5.0 (2.7-8.3)	13.2 (6.9-21.6)
40 y or older	2.6 (1.3-4.5)	7.3 (3.8-12.4)	19.7 (3.9-44.3)
Total	0.8 (0.5-1.2)	4.6 (3.1-6.7)	10.8 (6.8-15.8)

CI indicates confidence interval; and −, no CI.